- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Table of Contents
Case Reports in Medicine
Volume 2012 (2012), Article ID 649850, 3 pages
Severe Hemolytic Anemia Associated with Mild Pneumonia Caused by Mycoplasma pneumonia
Department of pediatrics, Ege University Faculty of Medicine, Izmir, 35100 Bornova, Turkey
Received 20 June 2012; Revised 30 July 2012; Accepted 30 July 2012
Academic Editor: Antoni Torres
Copyright © 2012 Zafer Kurugol et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
We report a case of M. pneumoniae infection presenting with severe hemolytic anemia in a 4-year-old girl, with a ten-day history of paleness, weakness, and nonproductive cough. She was very pale and tachycardic. However, she was not tachypneic. Chest examination showed normal breath sounds. No rhoncus or whistling was heard. As the erythrocyte sedimentation rate was excessively elevated, the differential diagnosis primarily comprised hematological malignancies. Direct Coombs' test was positive. Diagnosis of M. pneumoniae infection was confirmed by elevated levels of M. pneumoniae IgG and IgM antibodies and a chest X-ray suggestive of atypical pneumonia. The patient was treated with clarithromycin and packed red cell transfusion and showed a favorable recovery within ten days after admission. In conclusion, this case demonstrates that severe hemolytic anemia caused by M. pneumoniae is not always associated with severe pulmonary involvement, even when the respiratory infection is very mild, M. pneumoniae may be the cause of severe anemia.
Mycoplasma pneumoniae is a well-recognized cause of upper and lower respiratory tract infections and is usually diagnosed in middle and high school students, as discussed by Clyde . Symptoms and signs caused by M. pneumonia infection can be divided into two groups: those caused by respiratory tract infections and those caused by extrapulmonary disease. The most frequent clinical presentation of M. pneumoniae infection is tracheobronchitis and pneumonia. Extrapulmonary manifestations associated with M. pneumonia include hematologic, dermatologic, neurologic, musculoskeletal, renal, cardiac, and gastrointestinal complications. These extrapulmonary manifestations are uncommon and may present before, during, or after pulmonary signs, as discussed by Waites and Talkington . Hematological complications associated with M. pneumonia include hemolytic anemia, thrombocytopenia, thrombotic thrombocytopenic purpura, and hemophagocytosis as discussed by Waltes et al. . We report a case of severe hemolytic anemia associated with M. pneumoniae infection in a 4-year-old girl. In this reporting case, severe hemolytic anemia developed in the absence of marked clinical evidence of pneumonia.
A 4-year-old previously healthy girl was admitted to our hospital for severe anemia. Ten days before her admission, she had developed nonproductive cough and weakness and paleness. No family history of hemolytic attacks was noted. The patient had taken amoxicillin-clavulnate for seven days, but her complaints remained. On physical examination, the patient was very pale and tachycardic (140 beats/min). Blood pressure was 90/60 mmHg and body temperature was 36.8°C. Chest examination showed normal breath sounds. No rhoncus or whistling was heard. Respiratory rate was 20/minute. Systolic flow murmur was heard at every auscultation focus. The rest of the examination was unremarkable.
Admission blood count showed a haemoglobin level of 6.3 g/dl, a mean corpuscular volume of 83.1 fL, and white blood cell count of 11200/mm3, with 41% neutrophils, 51% lymphocytes, 8% monocytes, and a platelet count of 569000/mm3. The reticulocyte count was 6%. Lactate dehydrogenase (LDH) was 581 U/L (reference range: 100–250 U/L). Total bilirubin was 1.5 mg/dL (normal 0.1–1.0 mg/dL), of which 1.2 mg/dL was indirect (normal 0–0.8 mg/dL). Haptoglobin was 18 mg/dL (normal 30–200 mg/dL). The serum level of C-reactive protein was 0.81 mg/dL (reference range: 0–0.8 mg/dL), and the erythrocyte sedimentation rate exceeded 140 mm in 1 h. Other blood chemistry, liver profile, and coagulation studies were within normal limits. Blood, sputum and urine cultures were negative. The chest X-ray showed bilateral interstitial infiltration (Figure 1).
A bone marrow aspiration was performed to rule out the possibility of an underlying hematological malignancy, and it revealed mildly increased erythropoiesis but no changes indicative of a hematological malignancy were observed. Direct Coombs test was positive. Mycoplasma pneumoniae IgM antibody was positive; M. pneumoniae IgG antibody titers determined by immunofluorescence test were 1/64. The patient was diagnosed with severe hemolytic anemia complicating M. pneumoniae infection. She was treated with clarithromycin (15 mg/kg/d, twice daily) and packed red cell transfusion (10 mL/kg). Then the symptoms were rapidly resolved and hemoglobin increased to 10.4 gr/dL. The antibiotic was continued for a total of 10 days. The patient was discharged in good health after an 8-day hospital stay. In discharge, thrombocyte count, blood chemistry and coagulations studies were normal. Erythrocyte sedimentation rate was 40 mm/hour.
Four months after the discharge, she remained clinically well, her physical examination was normal; her hemoglobin was 13.8 gr/dL; M. pneumoniae IgM antibody was negative and M. pneumoniae IgG antibody titer was 1/64. Coombs test was found negative.
We report a case of M. pneumoniae infection presenting as severe hemolytic anemia. In this case, pulmonary signs and symptoms were restricted to mild nonproductive cough and interstitial infiltrates on chest radiography. At admission, because of the excessively high erythrocyte sedimentation rate, a hematological malignancy, that is, leukemia, was considered as being the probable diagnosis. But, bone marrow aspiration revealed no changes indicative of a hematological malignancy. In the presence of positive Coombs test, M. pneumoniae infection was suspected and diagnosis was subsequently confirmed by the detection of elevated antibody titers to M. pneumoniae.
M. pneumoniae frequently cause respiratory tract infections, as discussed by Clyde . Most patients with a respiratory infection have a respiratory tract disease without pneumonia and then they have pneumonia. One study suggested that 75–100% of infected patients with M. pneumoniae had an intractable, nonproductive cough, while only 3–10% developed pneumonia, as discussed by Mansel et al. . Our patient had nonproductive cough for ten-days, but there were no auscultation findings or dyspnea.
Mycoplasma pneumoniaeinfection has been associated with a variety of extrapulmonary sites. Extrapulmonary manifestations are seen in 20–25% of infected persons and may present before, during, after, or in the absence of pulmonary signs, as discussed by Walts et al. . Extrapulmonary manifestations include hematologic, dermatologic, neurologic, musculoskeletal, renal, cardiac, and gastrointestinal disorders. Hemolytic anemia is the most common hematologic manifestation, and thrombocytopenia, thrombotic thrombocytopenic purpura, hemophagocytosis, and hypercoagulability have been identified as possible hematological complications of M. pneumoniae infection, as discussed by Gursel et al. . Subclinical evidence of hemolytic anemia is present in most patients with pneumonia due to M. pneumoniae. However, severe hemolysis is extremely rare and is usually associated with severe pulmonary involvement, as discussed elsewhere [6, 7]. Although our patient did not have severe pulmonary disease, she developed severe hemolytic anemia which required blood transfusion. In this respect, our reported case is especially remarkable.
Antibodies (IgM) against the I antigen on human erythrocyte membranes appear during the course of M. pneumoniae infection and produce a cold agglutinin response, as discussed by Daxböck et al. . Serum cold agglutinin titers are elevated in half of adult patients with M. pneumoniae infection. However, the formation of cold agglutinins is a nonspecific early IgM reaction against the human erythrocyte I antigen. In children, the accuracy of the cold agglutinin test in detecting M. pneumoniae is not known, and the specificity and sensitivity are low, as discussed by Bradley et al. . In our patient, cold agglutinins were also negative, but Coombs test was found positive. A transient elevation in the thrombocyte count was also determined.
Hemolytic anemia associated with M. pneumoniae is usually self-limited and resolves spontaneously, but it may require transfusional support, as discussed by Gertz . In autoimmune hemolytic anemia, packed red blood cell transfusions can potentiate hemolysis and their use should be limited, as discussed by Gehrs and Friedberg . Nevertheless, transfusions are indicated and may be lifesaving in patients with severe anemia and/or cardiorespiratory compromise. The risk of transfusion-related hemolysis may be reduced by using an in-line blood warmer at 37°C and keeping the patient warm, as discussed by Gertz  Gehrs and Friedberg . Our patient with severe anemia was also transfused one unit of packed red blood cells and was treated with clarithromycin. There is limited, data which suggest that antibiotics are beneficial in mycoplasma associated hemolytic anemia, as discussed by Daxböck et al. . Antibiotics would not be expected to have a major therapeutic role in this setting because hemolytic process is thought to arise from immune-mediated mechanisms. However, treatment of the underlying mycoplasma infection may be associated with more rapid recovery of the hemolytic disease, as discussed by Gertz . Our patient rapidly recovered too after red blood cell transfusion and clarithromycin treatment.
In conclusion, this case demonstrates that severe hemolytic anemia caused by M. pneumoniae is not always associated with severe pulmonary involvement. Even in the absence of marked clinical evidence of pneumonia, M. pneumoniae may be the cause of severe anemia.
- W. A. Clyde Jr., “Clinical overview of typical Mycoplasma pneumoniae infections,” Clinical Infectious Diseases, vol. 17, supplement 1, pp. S32–S36, 1993.
- K. B. Waites and D. F. Talkington, “Mycoplasma pneumoniae and its role as a human pathogen,” Clinical Microbiology Reviews, vol. 17, no. 4, pp. 697–728, 2004.
- K. B. Waltes, M. F. Balish, and T. P. Atkinson, “New insights into the pathogenesis and detection of Mycoplasma pneumoniae infections,” Future Microbiology, vol. 3, no. 6, pp. 635–648, 2008.
- J. K. Mansel, E. C. Rosenow III, T. F. Smith, and J. W. Martin Jr., “Mycoplasma pneumoniae pneumonia,” Chest, vol. 95, no. 3, pp. 639–646, 1989.
- O. Gursel, D. Altun, A. A. Atay, O. Bedir, and A. E. Kurekci, “Mycoplasma pneumoniae infection associated with pancytopenia: a case report,” Journal of Pediatric Hematology/Oncology, vol. 31, no. 10, pp. 760–762, 2009.
- F. Daxböck, K. Zedtwitz-Liebenstein, H. Burgmann, and W. Graninger, “Severe hemolytic anemia and excessive leukocytosis masking mycoplasma pneumonia,” Annals of Hematology, vol. 80, no. 3, pp. 180–182, 2001.
- J. D. Cherry, “Mycoplasma and ureaplasma infections,” in Pediatric Infectious Diseases, R. D. Feigin and J. D. Cherry, Eds., pp. 2685–2714, Saunders, Philadelphia, Pa, USA, 6th edition, 2009.
- J. S. Bradley, C. L. Byington, S. S. Shah, et al., “The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America,” Clinical Infectious Diseases, vol. 53, pp. 25–76, 2011.
- M. A. Gertz, “Cold hemolytic syndrome,” Hematology, pp. 19–23, 2006.
- B. C. Gehrs and R. C. Friedberg, “Autoimmune hemolytic anemia,” American Journal of Hematology, vol. 69, no. 4, pp. 258–271, 2002.